ADVERTISEMENT
oligomannate alzheimer's disease neurodegeneration microbiome seaweed drug approval china
China Approves Alzheimer’s Treatment that Targets the Microbiome
Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.
China Approves Alzheimer’s Treatment that Targets the Microbiome
China Approves Alzheimer’s Treatment that Targets the Microbiome

Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.

Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.

microbiology, neurodegeneration, drug development

Inhaled Antibody Fragments Protect Infected Animals Against COVID-19
Roni Dengler, PhD | Jun 14, 2021 | 2 min read
Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.
ADVERTISEMENT